Clovis Oncology Inc Net debt/EBITDA
Quel est le Net debt/EBITDA de Clovis Oncology Inc?
Le Net debt/EBITDA de Clovis Oncology Inc est -11.04
Quelle est la définition de Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA des entreprises dans Health Care secteur sur NASDAQ par rapport à Clovis Oncology Inc
Entreprises avec net debt/ebitda similaire à Clovis Oncology Inc
- M&G Plc a Net debt/EBITDA de -11.08
- China Yurun Food a Net debt/EBITDA de -11.06
- Veritex Inc a Net debt/EBITDA de -11.06
- Fox Marble PLC a Net debt/EBITDA de -11.05
- Trisura a Net debt/EBITDA de -11.05
- Avantium NV a Net debt/EBITDA de -11.04
- Clovis Oncology Inc a Net debt/EBITDA de -11.04
- Wayside Technology Inc a Net debt/EBITDA de -11.00
- Alico a Net debt/EBITDA de -11.00
- Maxicity a Net debt/EBITDA de -10.99
- Huadian Fuxin a Net debt/EBITDA de -10.99
- Opiant Pharmaceuticals Inc a Net debt/EBITDA de -10.98
- Sigma Lithium a Net debt/EBITDA de -10.98